pyrroles has been researched along with Cancer of Cervix in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Kida, Y; Koshikawa, N; Lin, J; Nagase, H; Shinozaki, Y; Takenaga, K; Tsuji, K; Watanabe, T; Yamamoto, S; Yasui, N | 1 |
| Hippo, Y; Kida, Y; Koshikawa, N; Lin, J; Maru, Y; Nagase, H; Takenaga, K; Watanabe, T; Yamamoto, S; Yao, J; Zhu, Y | 1 |
| Hiraoka, K; Inoue, T; Koshikawa, N; Krishnamurthy, S; Lin, J; Nagase, H; Shinozaki, Y; Takatori, A; Watanabe, T; Yoda, H | 1 |
| Birrer, MJ; Chi, RA; Leaner, VD; van der Watt, P; Wei, W | 1 |
| Cai, D; Chen, Q; Li, M; Wu, X | 1 |
| Lan, S; Li, J; Liu, J; Liu, X; Wei, Z; Wu, M; Zhang, D; Zhang, X | 1 |
| Al Rawashdeh, W; Arns, S; Ehling, J; Gremse, F; Kiessling, F; Knüchel-Clarke, R; Kray, S; Lederle, W; Spöler, F | 1 |
| Aebischer, B; Akboga, MK; Akdamar, G; Alcalay, RN; Álvarez-Pérez, S; Aydogdu, S; Balci, KG; Barcaro, G; Bišová, K; Blanco, JL; Brewer, SH; Caruthers, SD; Ceylan, O; Chadwick, JA; Chang, DD; Che, JM; Chen, QQ; Chen, W; Chen, Z; Chung, M; Chung, W; Colecraft, HM; Coteli, E; Dogan, H; Dong, S; Elsig, S; Fahn, S; Fang, XJ; Feng, MG; Fenlon, EE; Floyd, KT; Fokdal, L; Ford, B; Fortunelli, A; Freudenberg, R; Gan-Or, Z; García, ME; Gillham, C; Giovannelli, D; Goertz, RS; Gulati, V; Haie-Meder, C; Hao, YY; Hatano, K; Hines, KJ; Hines, SM; Hirakawa, H; Hoskin, P; Hu, JH; Huang, P; Huang, Y; Hubicka, U; Inoue, Y; Ishii, N; Janssen, PM; Jin, Z; Johnson, A; Jürgenliemk-Schultz, I; Kaineder, K; Kamei, K; Kang, U; Karatas, F; Kash, TL; Katayama, Y; Keupp, J; Kirisits, C; Kisacik, H; Kodama, K; Kotzerke, J; Kryczyk, A; Kuhness, D; Kuo, S; Lanza, GM; Le Bris, N; Levin, DE; Levy, OA; Li, B; Li, H; Li, X; Liang, GD; Liang, Y; Liao, RQ; Lin, JT; Lindegaard, JC; Liong, C; Liu, B; Liu, C; Liu, GH; Liu, L; Liu, Q; Liu, X; Lowe, J; Lowery-Gionta, EG; Ma, YH; Maden, O; Mankad, V; Marder, KS; Marshall, SA; Martínez-Nevado, E; Maucksch, U; Mazeron, R; Mazzone, CM; Mazzoni, P; Mezricky, D; Mizokami, Y; Naumann, A; Navarro, M; Netzer, FP; Neurath, MF; Nie, Q; Oliva, P; Ozeke, O; Peláez, T; Pfeifer, L; Pleil, KE; Pomp, S; Pötter, R; Puckerin, AA; Rafael-Fortney, JA; Raman, SV; Rastogi, N; Řezanka, M; Řezanka, T; Rinker, JA; Rouleau, GA; Runge, R; Sahin, MD; Sakai, A; Schmieder, AH; Schmitz, AJ; Schultz, EJ; Šegedin, B; Sementa, L; Shen, Y; Shiotsuki, I; Shirahama, M; Staley, J; Starovoytov, V; Sterrer, M; Strobel, D; Sturdza, A; Subramanyam, P; Surnev, S; Swager, SA; Taeymans, J; Tan, H; Tan, LT; Tanderup, K; Temizhan, A; Terao, T; Thiele, TE; Tran, T; Tucker, MJ; Vetriani, C; Vítová, M; Wang, JP; Wang, L; Wang, M; Wang, X; Waters, CH; Weng, SX; Wickline, SA; Wildner, D; Wodarcyk, AJ; Wolf, P; Wu, L; Wu, YL; Wunderlich, G; Xiong, L; Xu, P; Yang, GS; Yang, XN; Yang, Y; Yayla, C; Ying, SH; Zachleder, V; Zhang, XG; Zhang, XK; Zhang, Y; Zheng, JY; Zhong, WZ; Zhu, J; Zhu, YJ; Żmudzki, P | 1 |
| Chen, SP; Chen, XQ; Fan, HS; Sun, J; Yang, Y; Zhang, XD; Zhao, H; Zhu, YD | 1 |
| Iacopetta, D; Longo, P; Parisi, OI; Puoci, F; Saturnino, C; Scrivano, L; Sinicropi, MS | 1 |
| Eisenhauer, EA; Ivy, P; Mackay, HJ; Oza, A; Sederias, J; Swenerton, K; Thomas, G; Tinker, A; Winquist, E | 1 |
| Bashkin, JK; Edwards, TG; Fisher, C; Fok, K; Helmus, M; Koeller, KJ; Slomczynska, U | 1 |
| Chang, JY; Chen, LT; Chen, YW; Cheung, CH; Chou, KM; Pan, WY; Tsou, TC; Yang, YN; Yeh, SC | 1 |
| Liang, X; Liu, J; Qian, X; Wang, F; Xie, L; Xu, K; Xu, Y | 1 |
| Ashoorzadeh, A; Denny, WA; Pruijn, FB; Stevenson, RJ; Tercel, M; van Leeuwen, WF | 1 |
| Bussolino, F; Capano, S; Casanovas, O; Giacca, M; Giraudo, E; Maione, F; Regano, D; Serini, G; Zentilin, L | 1 |
| Curran, WJ | 1 |
| Ishibashi, F; Iwao, M; Oda, T; Tanabe, S | 1 |
2 review(s) available for pyrroles and Cancer of Cervix
| Article | Year |
|---|---|
Topics: AC133 Antigen; Acenaphthenes; Acer; Acrosome Reaction; Adult; Agaricales; Aged; Aged, 80 and over; Animals; Animals, Zoo; Anti-Bacterial Agents; Anticoagulants; Antifungal Agents; Antimanic Agents; Antioxidants; Aortic Valve; Area Under Curve; ATP Binding Cassette Transporter, Subfamily G, Member 2; Bacillus; Bacterial Toxins; Bacterial Typing Techniques; Base Composition; Beauveria; Binge Drinking; Biomarkers; Bipolar Disorder; Blood Coagulation; Blotting, Western; Brachytherapy; Calcium Channels, L-Type; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Wall; Cells, Cultured; Ceramics; Chi-Square Distribution; China; Chlorophyll; Chlorophyta; Chloroplasts; Cholesterol, HDL; Chromatography, High Pressure Liquid; Chromobacterium; Clostridium perfringens; Clozapine; Constriction, Pathologic; Coronary Artery Bypass; Corticotropin-Releasing Hormone; Cross-Sectional Studies; Cytochrome P-450 CYP2C9; Dental Porcelain; Dental Restoration Failure; Dental Stress Analysis; Designer Drugs; Diaminopimelic Acid; DNA Fingerprinting; DNA, Bacterial; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Dosage Calculations; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Elasticity Imaging Techniques; Epsilonproteobacteria; Equipment Design; Ericaceae; Excitatory Amino Acid Antagonists; False Negative Reactions; Fatty Acids; Female; Food Analysis; Fresh Water; Gene Expression Regulation, Neoplastic; Glutathione; Graft Occlusion, Vascular; Heart Valve Prosthesis Implantation; Heart Ventricles; HEK293 Cells; Hemolymph; Humans; Hyaluronan Receptors; Hydrogen Peroxide; Hydrothermal Vents; Indoles; Inflammation Mediators; Inhibitory Concentration 50; Insecta; International Normalized Ratio; Isotope Labeling; Itraconazole; Kidney; Kinetics; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lamotrigine; Lanthanoid Series Elements; Limit of Detection; Linear Models; Lipid Peroxidation; Liver; Liver Cirrhosis; Logistic Models; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Malondialdehyde; Mediastinum; Metronidazole; Mice; Mice, Nude; Mice, Transgenic; Microbial Sensitivity Tests; Microscopy, Fluorescence; Middle Aged; Monocytes; Monomeric GTP-Binding Proteins; Multivariate Analysis; Myocytes, Cardiac; Neoplasm Staging; Neoplastic Stem Cells; Neural Pathways; Nitrates; Nucleic Acid Hybridization; Octamer Transcription Factor-3; Odds Ratio; Oxidation-Reduction; Oxidative Stress; Peptidoglycan; Phantoms, Imaging; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Phospholipids; Photolysis; Photosynthesis; Phylogeny; Plant Extracts; Polychaeta; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Prostatic Neoplasms; Pseudomonas aeruginosa; Pyrimidines; Pyrroles; Quorum Sensing; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Reference Values; Regression Analysis; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhizosphere; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Rutin; Saphenous Vein; Seawater; Selenium; Semen Preservation; Sensitivity and Specificity; Septal Nuclei; Sequence Analysis, DNA; Serum Albumin; Serum Albumin, Human; Shear Strength; Sodium Pertechnetate Tc 99m; Sodium-Hydrogen Exchangers; Soil Microbiology; SOXB1 Transcription Factors; Spain; Species Specificity; Sperm Motility; Spermatozoa; Spheroids, Cellular; Spores, Fungal; Stroke; Superoxide Dismutase; Swine; Tandem Mass Spectrometry; Technetium Compounds; Technetium Tc 99m Exametazime; Technetium Tc 99m Sestamibi; Temperature; Thiosulfates; Thrombosis; Thyroid Neoplasms; Transducers; Transfection; Transplantation, Heterologous; Treatment Outcome; Triazines; Tumor Burden; Urocortins; Uterine Cervical Neoplasms; Vacuoles; Valproic Acid; Ventral Tegmental Area; Vitamin K 2; Vitamin K Epoxide Reductases; Warfarin; Water Microbiology; Young Adult | 2016 |
New chemotherapeutic agents: update of major chemoradiation trials in solid tumors.
Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Angiostatins; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose Fractionation, Radiation; Drugs, Investigational; Endothelial Growth Factors; Enzyme Inhibitors; Esophageal Neoplasms; Farnesyltranstransferase; Female; Head and Neck Neoplasms; Humans; Indoles; Intercellular Signaling Peptides and Proteins; Isoenzymes; Laryngeal Neoplasms; Lung Neoplasms; Lymphokines; Male; Membrane Proteins; Neoplasms; Peptide Fragments; Plasminogen; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Pyrroles; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
1 trial(s) available for pyrroles and Cancer of Cervix
| Article | Year |
|---|---|
A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.
Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Indoles; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pyrroles; Sunitinib; Uterine Cervical Neoplasms | 2010 |
15 other study(ies) available for pyrroles and Cancer of Cervix
| Article | Year |
|---|---|
A linear five-ring pyrrole-imidazole polyamide-triphenylphosphonium conjugate targeting a mitochondrial DNA mutation efficiently induces apoptosis of HeLa cybrid cells carrying the mutation.
Topics: Antineoplastic Agents; Apoptosis; DNA, Mitochondrial; Female; HeLa Cells; Humans; Imidazoles; Mitophagy; Mutation; Nylons; Organoselenium Compounds; Pyrroles; Reactive Oxygen Species; Uterine Cervical Neoplasms | 2021 |
Anticancer effect of a pyrrole-imidazole polyamide-triphenylphosphonium conjugate selectively targeting a common mitochondrial DNA cancer risk variant in cervical cancer cells.
Topics: DNA, Mitochondrial; Female; HeLa Cells; Humans; Imidazoles; Nylons; Pyrroles; Uterine Cervical Neoplasms | 2023 |
Targeting the mutant PIK3CA gene by DNA-alkylating pyrrole-imidazole polyamide in cervical cancer.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Female; Gain of Function Mutation; Humans; Imidazoles; Mice; Nylons; Protein Kinase Inhibitors; Pyrroles; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; beta Karyopherins; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Drug Synergism; Drug Therapy, Combination; Female; Gene Expression Regulation, Neoplastic; Humans; Pyrroles; Quinoxalines; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2021 |
The homologous recombination protein RAD51 is a promising therapeutic target for cervical carcinoma.
Topics: Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; Female; HeLa Cells; Homologous Recombination; Humans; Molecular Targeted Therapy; Morpholines; Pyrroles; Rad51 Recombinase; Uterine Cervical Neoplasms | 2017 |
Semiconducting polymer-based nanoparticles for photothermal therapy at the second near-infrared window.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Female; Heating; HeLa Cells; Humans; Infrared Rays; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Phototherapy; Polymers; Pyrroles; Uterine Cervical Neoplasms | 2018 |
Optical tomography of MMP activity allows a sensitive noninvasive characterization of the invasiveness and angiogenesis of SCC xenografts.
Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Humans; Indoles; Matrix Metalloproteinases; Mice, Nude; Neovascularization, Pathologic; Pyrroles; Skin Neoplasms; Stromal Cells; Sunitinib; Tomography, Optical Coherence; Uterine Cervical Neoplasms; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2014 |
PPy@MIL-100 Nanoparticles as a pH- and Near-IR-Irradiation-Responsive Drug Carrier for Simultaneous Photothermal Therapy and Chemotherapy of Cancer Cells.
Topics: Antineoplastic Agents; Doxorubicin; Drug Carriers; Female; HeLa Cells; Humans; Hydrogen-Ion Concentration; Hyperthermia, Induced; Infrared Rays; Nanoparticles; Phototherapy; Polymers; Pyrroles; Uterine Cervical Neoplasms | 2016 |
Synthesis of sericin-based conjugates by click chemistry: enhancement of sunitinib bioavailability and cell membrane permeation.
Topics: Antineoplastic Agents; Biological Availability; Cell Membrane Permeability; Cell Survival; Click Chemistry; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; HeLa Cells; Humans; Indoles; Inhibitory Concentration 50; Protein Kinase Inhibitors; Pyrroles; Sericins; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Sunitinib; Technology, Pharmaceutical; Uterine Cervical Neoplasms | 2017 |
HPV episome levels are potently decreased by pyrrole-imidazole polyamides.
Topics: Antiviral Agents; Binding Sites; Bromodeoxyuridine; Cell Line, Tumor; Distamycins; DNA, Viral; Female; Human papillomavirus 16; Human papillomavirus 18; Human papillomavirus 31; Humans; Immunohistochemistry; Inhibitory Concentration 50; Microbial Sensitivity Tests; Nylons; Papillomavirus Infections; Plasmids; Pyrroles; Replication Origin; Uterine Cervical Neoplasms; Viral Load | 2011 |
Enhancement of non-homologous end joining DNA repair capacity confers cancer cells resistance to the novel selenophene compound, D-501036.
Topics: Antineoplastic Agents; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Repair; Drug Resistance, Neoplasm; Female; Humans; Organoselenium Compounds; Pyrroles; Up-Regulation; Uterine Cervical Neoplasms | 2011 |
Induction of G2/M phase arrest and apoptosis by potent antitumor APCA in human cervix carcinoma cells.
Topics: Acenaphthenes; Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Checkpoints; Cell Division; Cyclin B; Down-Regulation; Female; G2 Phase; HeLa Cells; Humans; Pyrroles; Uterine Cervical Neoplasms | 2011 |
The effect of a bromide leaving group on the properties of nitro analogs of the duocarmycins as hypoxia-activated prodrugs and phosphate pre-prodrugs for antitumor therapy.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Bromides; Cell Hypoxia; Female; Humans; Indoles; Male; Mice; Mice, Nude; Phosphates; Prodrugs; Pyrroles; Structure-Activity Relationship; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2011 |
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice.
Topics: Angiogenesis Inhibitors; Animals; Cell Hypoxia; Combined Modality Therapy; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Genetic Therapy; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Liver Neoplasms; Lymphatic Metastasis; Mice; Mice, Transgenic; Neoplasm Invasiveness; Neovascularization, Physiologic; Neuroendocrine Tumors; NF-kappa B; Pancreatic Neoplasms; Pericytes; Proto-Oncogene Proteins c-met; Pyrroles; Recombinant Proteins; Semaphorin-3A; Sunitinib; Tumor Burden; Uterine Cervical Neoplasms | 2012 |
Synthesis and structure-activity relationship study of lamellarin derivatives.
Topics: Alkaloids; Animals; Chlorocebus aethiops; Coumarins; Dogs; Drug Screening Assays, Antitumor; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Isoquinolines; Kidney; Mitomycin; Molecular Structure; Mollusca; Pyrroles; Rats; Sarcoma; Structure-Activity Relationship; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2002 |